In assessing other specific cytokines, we found no difference in IL-6 and IL-10 expression levels in KS lesions between groups with KS alone and those with KS and concurrent KAD, consistent with our prior study using bulk RNA-sequencing of both skin and GI KS lesions. This evidence concerns the gene IL6 and Kaposi's sarcoma.